DICE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DICE and buy or sell other stocks, ETFs, and their options commission-free!About DICE
DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J.
CEOJ. Kevin Judice, PhD
CEOJ. Kevin Judice, PhD
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2013
Founded2013
Employees—
Employees—
DICE Key Statistics
Market cap2.27B
Market cap2.27B
Price-Earnings ratio-20.33
Price-Earnings ratio-20.33
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$47.90
52 Week high$47.90
52 Week low$15.08
52 Week low$15.08
Stock Snapshot
The current DICE Therapeutics(DICE) stock price is $47.55, with a market capitalization of 2.27B. The stock trades at a price-to-earnings (P/E) ratio of -20.33.
On 2025-12-13, DICE Therapeutics(DICE) stock opened at —, reached a high of —, and a low of —.
The DICE Therapeutics(DICE)'s current trading volume is 0, compared to an average daily volume of 1.3M.
During the past year, DICE Therapeutics(DICE) stock moved between $15.08 at its lowest and $47.90 at its peak.
During the past year, DICE Therapeutics(DICE) stock moved between $15.08 at its lowest and $47.90 at its peak.
People also own
Based on the portfolios of people who own DICE. This list is generated using Robinhood data, and it’s not a recommendation.